Login
$LMRI
$11.74 +$0.08 (0.69%) Close

$LMRI SEC Filings

Filed On Filing
14 Aug 2026 SCHEDULE 13G
13 Aug 2026 10-Q
12 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
30 Jun 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
12 Jun 2026 Form 4: Lungren Matthew, Director

Received 19,358 shares as a grant or award

12 Jun 2026 Form 4: Mittl Robert Louis Jr., Director

Received 19,358 shares as a grant or award

12 Jun 2026 Form 4: Karlin Bridget E, Director

Received 19,358 shares as a grant or award

12 Jun 2026 Form 4: Joseph Molly, Director

Received 19,358 shares as a grant or award

12 Jun 2026 Form 4: Eisenberg Glenn A, Director

Received 19,358 shares as a grant or award

12 Jun 2026 Form 4: Cooper Henry Lee, Director

Received 19,358 shares as a grant or award

12 Jun 2026 Form 4: Brodnax Brett, Director

Received 19,358 shares as a grant or award

12 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders
21 May 2026 Form 4: Brodnax Brett, Director

Bought 35,000 shares ($254K)

18 May 2026 Form 4: Cooper Henry Lee, Director

Bought 30,000 shares ($223K)

12 May 2026 10-Q
12 May 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
28 Apr 2026 ARS
28 Apr 2026 DEFA14A
28 Apr 2026 Proxy statement: annual meeting on June 10, 2026
09 Apr 2026 8-K: Regulation FD Disclosure

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support